Epic Sciences Gets $52M More
socalTECH
SEPTEMBER 12, 2018
San Diego-based Epic Sciences , which is developing technology around personalization of cancer treatment and management, has raised $52M more in a Series E funding, the company's lead investor said this morning. Names of other investors in the round were not announced. Murali Prahalad, Ph.D. Epic has now raised more than $137.5M
Let's personalize your content